Close
Nordic 9Nordic 9

Valanx (private company)

Austria valanx.bio
See something wrong or missing? Let us know
Offices:Graz
Industry:BiotechHealth services
Business model:B2B

Valanx is a biotech startup in Austria developing a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development.

Investors: we tracked 7 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 3.55M

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Valanx

Name Criteria
Finland FinnAdvance
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
United Kingdom iLoF
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 2
  • At least one other investor: found 3
  • Total raised in a similar range: 1M - 5M USD
United Kingdom Novai
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Poland Molecule.one
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
France PEP-Therapy
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 2
  • At least one other investor: found 2
  • Total raised in a similar range: 1M - 5M USD
Sweden Nanolyze
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 2
  • At least one other investor: found 3
  • Total raised in a similar range: 1M - 5M USD
United Kingdom Sequential Skin
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 2
  • At least one other investor: found 2
  • Total raised in a similar range: 1M - 5M USD
United Kingdom Exogene
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 2
  • At least one other investor: found 2
  • Total raised in a similar range: 1M - 5M USD
United Kingdom Spirea
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 2
  • At least one other investor: found 2
  • Total raised in a similar range: 1M - 5M USD
United Kingdom Mable
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 2
  • At least one other investor: found 2
  • Total raised in a similar range: 1M - 5M USD
Top